0
Letters |

Omega-3 Fatty Acids and Cancer RiskOmega-3 Fatty Acids and Cancer Risk

JAMA. 2006;296(3):282-282. doi:10.1001/jama.296.3.282-a
Text Size: A A A
Published online

AUTHOR INFORMATION

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

OMEGA-3 FATTY ACIDS AND CANCER RISK

To the Editor: The systematic review of the effects of omega-3 fatty acids on cancer risk by Dr MacLean and colleagues1 concluded that dietary supplementation with omega-3 fatty acids is unlikely to prevent cancer. We would like to raise some of our concerns about this review.

Thirty-eight prospective studies were selected for review based on prespecified criteria. However, none of these studies measured fatty acid composition in patients. The food frequency questionnaire and dietary records correlate poorly with direct measurements of fatty acids in patient samples2 and are prone to measurement error.3 Ultimately, the effect of omega-3 fatty acids depends on levels achieved in individuals. Fish cannot synthesize omega-3 fatty acids de novo but rather ingest eicosapentaenoic and docosahexaenoic acid present in phytoplankton and zooplankton.4 Thus, some fish (especially farm-raised fish) are poor sources of omega-3 fatty acids. We therefore think that a more accurate conclusion of this study is that a preventive effect of omega-3 fatty acids on cancers is still uncertain.

We also disagree with the authors on their assessment that animal studies “do not come close to replicating human exposures.” Animal models, especially those developed recently, can closely mimic the clinical course of cancer progression, and are invaluable tools for mechanistic studies that cannot be performed in humans.5 6 Animal diets are designed with varying ratios of omega-3 to omega-6 fatty acids, both of which are essential fatty acids required for mammals to survive. It is the ratio of omega-3 to omega-6 that is important for deducing their mechanistic functions, and animal diets have been formulated to reflect human consumption.

Financial Disclosures: None reported.

References
MacLean CH, Newberry SJ, Mojica WA.  et al.  Effects of omega-3 fatty acids on cancer risk: a systematic review.  JAMA. 2006;295403-415
PubMed
Hunter DJ, Rimm EB, Sacks FM.  et al.  Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men.  Am J Epidemiol. 1992;135418-427
PubMed
Kipnis V, Subar AF, Midthune D.  et al.  Structure of dietary measurement error: results of the OPEN biomarker study.  Am J Epidemiol. 2003;15814-21
PubMed
Sargent JR. Fish oils and human diet.  Br J Nutr. 1997;78(suppl 1)  S5-S13
PubMed
Maddison K, Clarke AR. New approaches for modelling cancer mechanisms in the mouse.  J Pathol. 2005;205181-193
PubMed
Ward JM, Devor-Henneman DE. Mouse models of human familial cancer syndromes.  Toxicol Pathol. 2004;32(suppl 1)  90-98
PubMed

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

MacLean CH, Newberry SJ, Mojica WA.  et al.  Effects of omega-3 fatty acids on cancer risk: a systematic review.  JAMA. 2006;295403-415
PubMed
Hunter DJ, Rimm EB, Sacks FM.  et al.  Comparison of measures of fatty acid intake by subcutaneous fat aspirate, food frequency questionnaire, and diet records in a free-living population of US men.  Am J Epidemiol. 1992;135418-427
PubMed
Kipnis V, Subar AF, Midthune D.  et al.  Structure of dietary measurement error: results of the OPEN biomarker study.  Am J Epidemiol. 2003;15814-21
PubMed
Sargent JR. Fish oils and human diet.  Br J Nutr. 1997;78(suppl 1)  S5-S13
PubMed
Maddison K, Clarke AR. New approaches for modelling cancer mechanisms in the mouse.  J Pathol. 2005;205181-193
PubMed
Ward JM, Devor-Henneman DE. Mouse models of human familial cancer syndromes.  Toxicol Pathol. 2004;32(suppl 1)  90-98
PubMed
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.